Skip to main content
. Author manuscript; available in PMC: 2010 Sep 15.
Published in final edited form as: Biochem Pharmacol. 2009 May 13;78(6):617–624. doi: 10.1016/j.bcp.2009.05.011

Figure 5.

Figure 5

Hypothermic effects induced by harmaline (5 and 15 mg/kg, i.p.) in wild-type and Tg-CYP2D6 mice. Values represent mean ± SD (N = 8 in each group). For the high dose (15 mg/kg), significant difference is shown for the variations of CYP2D6 genotype and time (P < 0.001; two-way ANOVA). Difference (*P < 0.05, **P < 0.01) is also noted between the two genotyped mice treated with 15 mg/kg harmaline at specific time points.